Drugs and Devices

FDA permits marking of mobile app for glucose monitoring

On January 23, the U.S. Food and Drug Administration (FDA) permitted marketing of the first set of mobile medical apps that allow people with diabetes to automatically and securely share data from a continuous glucose monitor with other people in real-time using an Apple mobile device such as an iPhone.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Newsletter Subscribe

  • This field is for validation purposes and should be left unchanged.

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing

Shares